creatine has been researched along with Infant, Premature, Diseases in 9 studies
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Because these issues may be operative in apnea of prematurity (AOP), we hypothesized that CS reduces episodes of hypoxemia and bradycardia in infants with AOP." | 9.11 | Randomized, controlled trial of oral creatine supplementation (not effective) for apnea of prematurity. ( Bohnhorst, B; Dördelmann, M; Geuting, T; Peter, CS; Poets, CF; Wilken, B, 2004) |
| " Because these issues may be operative in apnea of prematurity (AOP), we hypothesized that CS reduces episodes of hypoxemia and bradycardia in infants with AOP." | 5.11 | Randomized, controlled trial of oral creatine supplementation (not effective) for apnea of prematurity. ( Bohnhorst, B; Dördelmann, M; Geuting, T; Peter, CS; Poets, CF; Wilken, B, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Illapani, VSP | 1 |
| Edmondson, DA | 1 |
| Cecil, KM | 1 |
| Altaye, M | 1 |
| Kumar, M | 1 |
| Harpster, K | 1 |
| Parikh, NA | 1 |
| Basu, SK | 1 |
| Pradhan, S | 1 |
| Kapse, K | 1 |
| McCarter, R | 1 |
| Murnick, J | 1 |
| Chang, T | 1 |
| Limperopoulos, C | 1 |
| Gimpel, C | 1 |
| Krause, A | 1 |
| Franck, P | 1 |
| Krueger, M | 1 |
| von Schnakenburg, C | 1 |
| Bohnhorst, B | 1 |
| Geuting, T | 1 |
| Peter, CS | 1 |
| Dördelmann, M | 1 |
| Wilken, B | 1 |
| Poets, CF | 1 |
| Gawlowski, Z | 1 |
| Aladangady, N | 1 |
| Coen, PG | 1 |
| Csaicsich, D | 1 |
| Russo-Schlaff, N | 1 |
| Messerschmidt, A | 1 |
| Weninger, M | 1 |
| Pollak, A | 1 |
| Aufricht, C | 1 |
| Mathew, OP | 1 |
| Jones, AS | 1 |
| James, E | 1 |
| Bland, H | 1 |
| Groshong, T | 1 |
| Vigneron, DB | 1 |
| Barkovich, AJ | 1 |
| Noworolski, SM | 1 |
| von dem Bussche, M | 1 |
| Henry, RG | 1 |
| Lu, Y | 1 |
| Partridge, JC | 1 |
| Gregory, G | 1 |
| Ferriero, DM | 1 |
| Simon, HJ | 1 |
| Axline, SG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Early Sodium Intake in Preterm Newborns; Randomized Clinical Trial[NCT04035564] | Phase 4 | 52 participants (Actual) | Interventional | 2018-03-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The difference between initial weight and 72hrs weight, expressed in percentage of birth weight. (NCT04035564)
Timeframe: Initial weight (baseline) vs 72 hours
| Intervention | % of birth weight (Mean) |
|---|---|
| Sodium < 1mEq/kg/Day | -9.206 |
| Sodium 5mEq/kg/Day | -6.345 |
The difference between current serum sodium and initial serum sodium (NCT04035564)
Timeframe: Initial serum sodium (baseline) vs 72 hours
| Intervention | mEq/L (Mean) |
|---|---|
| Sodium < 1mEq/kg/Day | 1.921 |
| Sodium 5mEq/kg/Day | 5.71 |
serum sodium >150mEq/L (NCT04035564)
Timeframe: 72 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 1 |
| Sodium 5mEq/kg/Day | 1 |
serum sodium <130mEq/L (NCT04035564)
Timeframe: 72 hours
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 6 |
| Sodium 5mEq/kg/Day | 1 |
Death during hospitalization. (NCT04035564)
Timeframe: Patients will be followed during hospitalization, an expected average of 3 months of age
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 5 |
| Sodium 5mEq/kg/Day | 2 |
Bleeding into the brain´s ventricular system (intracranial ultrasound). (NCT04035564)
Timeframe: Patients will be followed during hospitalization, an expected average of 3 months of age
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 6 |
| Sodium 5mEq/kg/Day | 4 |
Positive blood culture and/or 5 days of continuous antimicrobial therapy (NCT04035564)
Timeframe: Patients will be followed during hospitalization, an expected average of 3 months of age
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 8 |
| Sodium 5mEq/kg/Day | 5 |
"Number of patients with Bell stage II or greater necrotizing enterocolitis~Bell's Staging:~Stage II A:~Gastrointestinal signs: Increasing gastric aspirates, mild abdominal distention, fecal occult blood, absent bowel sounds.~Systemic signs: Temperature instability, apnea, bradycardia, lethargy. Radiological findings: Intestinal dilatation, ileus, pneumatosis intestinalis.~Stage II B:~Gastrointestinal signs: As stage IIA plus abdominal tenderness. Systemic signs: As stage IIA plus metabolic acidosis and thrombocytopenia. Radiological findings: As stage IIA plus portal vein gas and ascites.~Stage III A:~Gastrointestinal signs: As stage IIB plus marked abdominal tenderness and generalised peritonitis.~Systemic signs: As stage IIB plus hypotension and severe apnea. Radiological findings: As stage IIB~Stage III B:~Gastrointestinal signs: As stage IIIA As stage IIIA As stage IIIA plus pneumoperitoneum" (NCT04035564)
Timeframe: Patients will be followed during hospitalization, an expected average of 3 months of age
| Intervention | Participants (Count of Participants) |
|---|---|
| Sodium < 1mEq/kg/Day | 2 |
| Sodium 5mEq/kg/Day | 2 |
The difference between current weight and initial weight (NCT04035564)
Timeframe: Initial weight (baseline) vs 72 hours
| Intervention | Grams (Mean) |
|---|---|
| Sodium < 1mEq/kg/Day | -135.43 |
| Sodium 5mEq/kg/Day | -96.05 |
1 trial available for creatine and Infant, Premature, Diseases
| Article | Year |
|---|---|
Randomized, controlled trial of oral creatine supplementation (not effective) for apnea of prematurity.
Topics: Apnea; Bradycardia; Creatine; Double-Blind Method; Humans; Hypoxia; Infant, Newborn; Infant, Prematu | 2004 |
8 other studies available for creatine and Infant, Premature, Diseases
| Article | Year |
|---|---|
Magnetic resonance spectroscopy brain metabolites at term and 3-year neurodevelopmental outcomes in very preterm infants.
Topics: Brain; Child, Preschool; Choline; Creatine; Female; Fetal Growth Retardation; Humans; Infant; Infant | 2022 |
Third Trimester Cerebellar Metabolite Concentrations are Decreased in Very Premature Infants with Structural Brain Injury.
Topics: Aspartic Acid; Brain; Brain Injuries; Cerebellum; Choline; Creatine; Female; Gestational Age; Gray M | 2019 |
Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants.
Topics: Birth Weight; Calcium; Creatine; Diuretics; Female; Furosemide; Gestational Age; Humans; Infant, New | 2010 |
Hypernatraemia in preterm infants born at less than 27 weeks gestation.
Topics: Birth Weight; Creatine; Ductus Arteriosus, Patent; Enterocolitis, Necrotizing; Female; Fluid Therapy | 2006 |
Renal failure, comorbidity and mortality in preterm infants.
Topics: Acute Kidney Injury; Austria; Cause of Death; Child, Preschool; Cohort Studies; Creatine; Female; Fo | 2008 |
Neonatal renal failure: usefulness of diagnostic indices.
Topics: Acute Kidney Injury; Anuria; Creatine; Diagnosis, Differential; Gestational Age; Humans; Infant, New | 1980 |
Three-dimensional proton MR spectroscopic imaging of premature and term neonates.
Topics: Aspartic Acid; Brain; Brain Mapping; Cerebral Hemorrhage; Choline; Chorioamnionitis; Creatine; Energ | 2001 |
Clinical pharmacology of kanamycin in premature infants.
Topics: Adult; Creatine; Humans; Infant, Newborn; Infant, Premature, Diseases; Injections, Intramuscular; Ka | 1966 |